Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density-The CONFORS Study

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

(2014) Benjamin Z. Leder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial

(2013) Joy N Tsai et al.   LANCET

Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density

(2012) Christian Muschitz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene

(2012) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?

(2011) E. Michael Lewiecki   CURRENT MEDICAL RESEARCH AND OPINION

Combination antiresorptive and osteoanabolic therapy for osteoporosis: We are not there yet

(2011) Natalie E. Cusano et al.   CURRENT MEDICAL RESEARCH AND OPINION

Present at the beginning: a personal reminiscence on the history of teriparatide

(2011) R. Marcus   OSTEOPOROSIS INTERNATIONAL

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis

(2010) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

(2010) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice

(2009) Christina Keel et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent

(2009) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Teriparatide Retreatment in Osteoporotic Men and Women

(2009) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

(2008) Barbara M Obermayer-Pietsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*

(2008) Richard Eastell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate

(2008) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate

(2008) Paul D. Miller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window

(2008) John P. Bilezikian   Current Osteoporosis Reports

Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis

(2007) Steven Boonen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM